Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Revance Therapeutics (NQ: RVNC ) 5.810 +0.010 (+0.17%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Revance Therapeutics < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Revance Announces Two Publications Highlighting the Efficacy and Safety Profile of DAXXIFY™ (DaxibotulinumtoxinA-lanm) For Injection in the Aesthetic Surgery Journal September 19, 2022 From Revance Therapeutics, Inc. Via Business Wire Revance to Present Data from Phase 2 JUNIPER Clinical Trial Evaluating DAXXIFY™ (DaxibotulinumtoxinA-lanm) Injection for the Treatment of Upper Limb Spasticity at the International Congress of Parkinson and Movement Disorder Society (MDS) September 15, 2022 From Revance Therapeutics, Inc. Via Business Wire Revance Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares September 15, 2022 From Revance Therapeutics, Inc. Via Business Wire With New Growth Avenues, Analysts Boost Price Targets For This Botox Competitor September 09, 2022 Via Benzinga Analyst Ratings for Revance Therapeutics September 09, 2022 Revance Therapeutics (NASDAQ:RVNC) has observed the following analyst ratings within the last quarter: Via Benzinga 5 Analysts Have This to Say About Revance Therapeutics September 09, 2022 Within the last quarter, Revance Therapeutics (NASDAQ:RVNC) has observed the following analyst ratings: Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session September 13, 2022 Via Benzinga Relay Therapeutics, Rent the Runway And Some Other Big Stocks Moving Lower In Today's Pre-Market Session September 13, 2022 U.S. stock futures traded higher this morning ahead of the much-awaited inflation data for August. Here are some big stocks moving lower in today’s pre-market trading session. Via Benzinga Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket September 13, 2022 Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) rose 41.7% to $2.72 in pre-market trading. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an average... Via Benzinga New 483 Observations Unlikely to Impact Much Awaited Revance's Daxi Approval, Says This Analyst August 10, 2022 Via Benzinga Revance Therapeutics: Q2 Earnings Insights August 09, 2022 Revance Therapeutics (NASDAQ:RVNC) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Via Benzinga Revance Announces Pricing of $200.0 Million Upsized Public Offering of Common Stock September 12, 2022 From Revance Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's After-Market Session September 12, 2022 Gainers OpGen (NASDAQ:OPGN) shares rose 20.6% to $0.52 during Monday's after-market session. This security traded at a volume of 927.4K shares come close, making up 324.6% of its average volume over... Via Benzinga Revance Announces Proposed Public Offering of Common Stock September 12, 2022 From Revance Therapeutics, Inc. Via Business Wire Needham Maintains Buy Rating for Revance Therapeutics: Here's What You Need To Know September 09, 2022 Needham has decided to maintain its Buy rating of Revance Therapeutics (NASDAQ:RVNC) and raise its price target from $25.00 to $35.00. Shares of Revance Therapeutics are trading up 9.72% over the last... Via Benzinga What 5 Analyst Ratings Have To Say About Revance Therapeutics September 09, 2022 Revance Therapeutics (NASDAQ:RVNC) has observed the following analyst ratings within the last quarter: Via Benzinga Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday September 09, 2022 Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... Via Benzinga Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary September 08, 2022 Via Benzinga Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session September 08, 2022 Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders. Via Benzinga AAPL Stock Alert: 13 Takeaways From the Latest Apple Event 2022 September 08, 2022 Apple (AAPL) stock is a hot topic on Thursday following the tech giant's latest event showing off new products and we've got the details! Via InvestorPlace Why Is Revance Therapeutics (RVNC) Stock Soaring Today? September 08, 2022 RVNC stock is jumping 12% after the FDA approved its alternative to AbbVie's Botox. Revance's injection is supposed to last longer than Botox. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 08, 2022 Via Benzinga Revance Shares Shoot Higher As FDA Cleared DAXXIFY Injection For Frown Lines September 08, 2022 The United States Food and Drug Administration (FDA) has approved Revance Therapeutics’ (NASDAQ: RVNC) lead asset DAXXIFY (DaxibotulinumtoxinA-lanm) for injection for the temporary improvement of... Via Benzinga Why Asana Is Trading Higher By 24%; Here Are 24 Stocks Moving Premarket September 08, 2022 Gainers Asana, Inc. (NYSE: ASAN) rose 24.1% to $23.62 in pre-market trading after the company reported better-than-expected results for its second quarter and issued a strong sales guidance. Via Benzinga Revance Announces FDA Approval of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection, the First and Only Peptide-Formulated Neuromodulator With Long-Lasting Results September 08, 2022 From Revance Therapeutics, Inc. Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session September 07, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know August 31, 2022 After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar. Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session August 15, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga Revance Reports Second Quarter 2022 Financial Results, Provides Corporate Update August 09, 2022 From Revance Therapeutics, Inc. Via Business Wire Earnings Scheduled For August 9, 2022 August 09, 2022 Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
